Subscribe To

Price Alert Latest News Economic Calendar News

THTX / Theratechnologies Inc. (THTX) CEO Paul Levesque on Q1 2022 Results - Earnings Call Transcript

Theratechnologies Inc. (NASDAQ:THTX ) Q1 2022 Earnings Conference Call April 12, 2022 8:30 AM ET Company Participants Paul Levesque - President & CEO Philippe Dubuc - SVP & CFO Christian Marsolais - SVP & Chief Medical Officer John Mullaly - IR, LifeSci Advisors Conference Call Participants Andre Uddin - Mackie Research Capital Stephen Kwai - National Bank Financial Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies First Quarter Fiscal Year 2022 Earnings Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Theratechnologies

Inc

THTX

Paul

Levesque

2022

Results

thtx

Earnings

Transcript

Stock

Posted: Apr 13 2022, 14:55

Author Name: Seeking Alpha

THTX News

By InvestorPlace
October 26, 2023

Why Is Theratechnologies (THTX) Stock Down 22% Today?

Theratechnologies (NASDAQ: THTX ) stock is dropping on Thursday after the biopharmaceutical company announced a proposed public share offering. Thera

By GlobeNewsWire
September 7, 2023

Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference

MONTREAL, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biophar

By GlobeNewsWire
May 25, 2023

Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023

MONTREAL, May 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharma

By Proactive Investors
April 14, 2023

Theratechnologies stock price continues higher on company guidance

Theratechnologies (TSX:TH) Inc shares continued to advance Friday, up 12% to $1.29 following a 10% gain on Thursday, after the biopharmaceutical compa

By Seeking Alpha
April 12, 2023

Theratechnologies Inc. (THTX) Q1 2023 Earnings Call Transcript

Theratechnologies Inc. (NASDAQ:THTX ) Q1 2023 Earnings Conference Call April 12, 2023 8:30 AM ET Company Participants Elif McDonald - Head of Investor

By Proactive Investors
April 12, 2023

Theratechnologies shares up as first quarter revenues rise

Theratechnologies (TSX:TH) has reported first-quarter financial results with consolidated revenue growing by 7% to US$19.9mln. The Montreal-headquarte

By GlobeNewsWire
March 14, 2023

Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model

MONTREAL, March 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biophar

By GlobeNewsWire
February 14, 2023

Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update

MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company foc

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.